Brickell Biotech Inc (BBI)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Reginald L. Hardy
Employees:
30
5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
(720) 505-4755

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of various prescription therapeutics for the treatment of debilitating skin diseases in the United States.

Data derived from most recent annual or quarterly report
Market Cap 23.585 Million Shares Outstanding115.048 Million Avg 30-day Volume 17.311 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.29
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value38.649 Million
Current Ratio5.724 EPS Growth0 Quick Ratio5.089
1 Yr BETA 0.5656 52-week High/Low 1.7 / 0.2 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score0.0 Free Cash Flow to Firm 0
View SEC Filings from BBI instead.

View recent insider trading info

Funds Holding BBI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BBI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LUCHI MONICA E. CHIEF MEDICAL OFFICER

  • Officer
400,000 2021-09-03 2

HARDY REGINALD L CHAIRMAN OF THE BOARD

  • Officer
  • Director
1,128,876 2021-07-23 2

MCAVOY DAVID R. GENERAL COUNSEL AND CCO

  • Officer
142,859 2021-07-23 4

LYONS GARY A

  • Director
40,000 2021-06-14 1

MARCHIO ALBERT N II CHIEF FINANCIAL OFFICER

  • Officer
20,000 2021-06-14 1

SAMANT VIJAY B

  • Director
40,000 2021-06-14 1

VERU DENNISON T

  • Director
40,000 2021-06-14 1

SKLAWER ANDREW D COO AND SECRETARY

  • Officer
250,000 2021-06-14 3

BROWN ROBERT BUSARD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
750,000 2021-06-14 2

BRETON JOSE CHIEF ACCOUNTING OFFICER

  • Officer
85,000 2021-06-14 2

CHADHA DEEPAK CHIEF RESEARCH & DEV. OFFICER

  • Officer
250,000 2021-06-14 3

CARRUTHERS R MICHAEL CHIEF FINANCIAL OFFICER

0 2020-03-16 0

LEVY ADAM SCOTT CHIEF BUSINESS OFFICER

0 2020-03-16 0

ABERCROMBIE GEORGE B CHIEF EXECUTIVE OFFICER

138,424 2020-02-14 0

AHUJA SANJEEV CHIEF MEDICAL OFFICER

0 2019-11-04 0

JU WILLIAM

13,363 2019-08-31 0

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • 10% Owner
No longer subject to file 2019-01-10 0

MORROW GEORGE J

  • Director
0 2018-05-23 0

DOUGLAS R GORDON

  • Director
0 2018-05-23 0

MERTON ROBERT C

  • Director
0 2018-05-23 0

SHENK THOMAS E

  • Director
0 2018-05-23 0

BELESON RICHARD M

  • Director
0 2018-05-23 0

RAMOS ANTHONY ALAN VP, CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-08 0

SMITH LAWRENCE RUSSELL SR VP, RESEARCH

  • Officer
0 2018-01-08 0

MAMMEN MAMMEN SR VP, CLINICAL DEVELOPMENT

  • Officer
0 2018-01-08 0

ANGES MG, INC.

2,058,528 2016-08-02 0

BILINSKY IGOR SR VP, CORPORATE DEVELOPMENT

  • Officer
193,798 2015-07-13 0

SHERWIN STEPHEN A

  • Director
22,003 2015-05-21 0

SINGER JAMES R

  • 10% Owner
No longer subject to file 2013-09-12 0

ROLLAND ALAIN P PHD EXEC VP, PRODUCT DEVELOPMENT

  • Officer
No longer subject to file 2013-08-22 0

BROADFOOT JILL MARIE SR VICE PRESIDENT, CFO, SEC

  • Officer
No longer subject to file 2013-04-01 0

CAMPBELL ROBERT H

  • Director
14,328 2012-10-19 0

PETERSON ERIC H EVP, GENERAL COUNSEL & SECTRY

  • Officer
864,664 2009-12-17 0

CASEY THOMAS M. EVP & CFO

  • Officer
1,582,332 2009-12-17 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
No longer subject to file 2009-07-24 0

V-SCIENCES INVESTMENTS PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
No longer subject to file 2009-05-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BRICKELL BIOTECH INC BBI 2022-01-28 16:45:04 UTC -8.6356 8.7056 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 16:15:03 UTC -8.6356 8.7056 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 15:45:04 UTC -8.6356 8.7056 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 15:15:03 UTC -8.6356 8.7056 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 14:45:03 UTC -8.7127 8.7827 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 14:15:03 UTC -8.7127 8.7827 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 13:45:03 UTC -8.7127 8.7827 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 13:15:03 UTC -8.7127 8.7827 2400000
BRICKELL BIOTECH INC BBI 2022-01-28 12:45:03 UTC -8.7127 8.7827 2400000
BRICKELL BIOTECH INC BBI 2022-01-27 22:15:03 UTC -8.7127 8.7827 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 21:45:03 UTC -8.7127 8.7827 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 21:15:03 UTC -8.7127 8.7827 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 20:45:03 UTC -11.4411 11.5111 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 20:15:04 UTC -11.4411 11.5111 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 19:45:03 UTC -11.4411 11.5111 2000000
BRICKELL BIOTECH INC BBI 2022-01-27 19:15:03 UTC -11.4411 11.5111 2100000
BRICKELL BIOTECH INC BBI 2022-01-27 18:45:03 UTC -11.4411 11.5111 2100000
BRICKELL BIOTECH INC BBI 2022-01-27 18:15:03 UTC -11.4411 11.5111 2100000
BRICKELL BIOTECH INC BBI 2022-01-27 17:45:03 UTC -11.4411 11.5111 2100000
BRICKELL BIOTECH INC BBI 2022-01-27 17:15:03 UTC -11.4411 11.5111 2100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments